Recombinant granulocyte colony-stimulating factor injection administered post-chemotherapy to mitigate neutropenia. Acquired by hematology-oncology departments in hospitals for supportive care in cancer therapy. Manufactured and supplied by biopharmaceutical companies to global oncology networks.